CCFM
BIOTU

Cohen & Co Financial Management’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Cohen & Co Financial Management’s Portfolio BIOTU Stock Details BIOTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,000
Closed -$1M – 156
2021
Q3 		$1M Hold
100,000
– – 0.42% 87
2021
Q2 		$1.01M Buy
+100,000
New +$1M 0.64% 46

Other funds holding BIOTU

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cohen & Co Financial Management's BIOTU Position: Q4 2021 in Review

Cohen & Co Financial Management sold out of Biotech Acquisition Company Unit (BIOTU) in Q4 2021, closing a stake of 100,000 shares — an estimated $1M sold.

Cohen & Co Financial Management first reported a position in BIOTU in Q2 2021 and held it in 2 quarters. The position peaked at $1.01M in Q2 2021. 15 funds tracked by Wall St. Rank hold BIOTU as of Q4 2021.

  • Cohen & Co Financial Management reported no remaining Biotech Acquisition Company Unit position as of Q4 2021 after selling out during the quarter.
  • Cohen & Co Financial Management sold 100,000 Biotech Acquisition Company Unit shares in Q4 2021, an estimated $1M.
  • Cohen & Co Financial Management first reported a position in Biotech Acquisition Company Unit in Q2 2021 and held it in 2 quarters.
  • Cohen & Co Financial Management's Biotech Acquisition Company Unit position peaked at $1.01M in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q4 2021.

Based on Cohen & Co Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.